Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Umesh Alavadi"'
Autor:
Radha Gopalaswamy, Nishant Kumar, Himanshu Vashistha, Priya Rajendran, Jyoti Kayesth, Carel Joseph Peravali, Satabdi Kashyap, Shreeparna Ghosh, Habakkuk Yumo, Moe Moore, Sridhar Anand, Ranjani Ramachandran, Umesh Alavadi, Sanjeev Saini, Sivakumar Shanmugam
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
IntroductionTruenat MTB-RIF assay (Truenat), a nucleic acid amplification test (NAAT), is a real-time polymerase chain reaction (RT-PCR) chip-based assay that can detect Mycobacterium tuberculosis (Mtb) and rifampicin (RIF) drug resistance using port
Externí odkaz:
https://doaj.org/article/35d56f60092b4ac2ac185fef14435d43
Autor:
Rajesh Raju, Banuru Muralidhara Prasad, Umesh Alavadi, Sanjeev Saini, Mukesh Sabharwal, Akshay Duhan, Sridhar Anand, Manohar Lal, Harpreet Kaur, Neerja Arora, Jyoti Jaju, Moe Moore, Ranjani Ramachandran, Nishant Kumar, Rajendra P. Joshi
Publikováno v:
Diagnostics, Vol 13, Iss 17, p 2823 (2023)
The complete diagnostic evaluation of tuberculosis based on its drug-resistance profile is critical for appropriate treatment decisions. The TB diagnostic landscape in India has been transformed with the scaling-up of WHO-recommended diagnostics, but
Externí odkaz:
https://doaj.org/article/56820990dbaf4a25a4414e8b24d4712b
Autor:
Malaisamy Muniyandi, Paranchi Murugesan Ramesh, William A. Wells, Umesh Alavadi, Suvanand Sahu, Chandrasekaran Padmapriyadarsini
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 8, Iss 8, p 411 (2023)
Objective: To measure the economic impacts of the longer pre-XDR-TB treatment regimen and the shorter BEAT-TB India regimen. Methods: In the current study, the economic impacts of the current 18-month pre-XDR-TB treatment regimen and the 6–9 month
Externí odkaz:
https://doaj.org/article/8364645f731f4b13bdc32877c4faf795
Autor:
Kuldeep Singh Sachdeva, Neeraj Raizada, Achuthan Sreenivas, Anna H Van't Hoog, Susan van den Hof, Puneet K Dewan, Rahul Thakur, R S Gupta, Shubhangi Kulsange, Bhavin Vadera, Ameet Babre, Christen Gray, Malik Parmar, Mayank Ghedia, Ranjani Ramachandran, Umesh Alavadi, Nimalan Arinaminpathy, Claudia Denkinger, Catharina Boehme, C N Paramasivan
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0126065 (2015)
BACKGROUND:Xpert MTB/RIF, the first automated molecular test for tuberculosis, is transforming the diagnostic landscape in high-burden settings. This study assessed the impact of up-front Xpert MTB/RIF testing on detection of pulmonary tuberculosis (
Externí odkaz:
https://doaj.org/article/9d2bfa50b7ed46cdb6ed12f56b4d6ed6
Autor:
Neeraj Raizada, K S Sachdeva, Achuthan Sreenivas, Bhavin Vadera, R S Gupta, Malik Parmar, Shubhangi Kulsange, Ameet Babre, Rahul Thakur, Christen Gray, Ranjani Ramachandran, Umesh Alavadi, Mayank Ghedia, Balasangameshwara Vollepore, Puneet Dewan, Catharina Boehme, C N Paramsivan
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89301 (2014)
BackgroundXpert MTB/RIF is an automated cartridge-based nucleic acid amplification test that has demonstrated its potential to detect tuberculosis and rifampicin resistance with high accuracy. To assist scale-up decisions in India, a feasibility asse
Externí odkaz:
https://doaj.org/article/ed66ce922a7f43159eed36f5f65af6c4
Autor:
Neeraj Raizada, Kuldeep Singh Sachdeva, Sreenivas Achuthan Nair, Shubhangi Kulsange, Radhey Shayam Gupta, Rahul Thakur, Malik Parmar, Christen Gray, Ranjani Ramachandran, Bhavin Vadera, Shobha Ekka, Shikha Dhawan, Ameet Babre, Mayank Ghedia, Umesh Alavadi, Puneet Dewan, Mini Khetrapal, Ashwini Khanna, Catharina Boehme, Chinnambedu Nainarappan Paramsivan
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e105346 (2014)
BACKGROUND:Diagnosis of pulmonary tuberculosis (PTB) in children is challenging due to difficulties in obtaining good quality sputum specimens as well as the paucibacillary nature of disease. Globally a large proportion of pediatric tuberculosis (TB)
Externí odkaz:
https://doaj.org/article/763946fbf68b40049a8255ed7b982ae3
Autor:
Chandrasekaran, Padmapriyadarsini, Vikram, Vohra, Anuj, Bhatnagar, Rajesh, Solanki, Rathinam, Sridhar, Lalitkumar, Anande, M, Muthuvijaylakshmi, Miraa, Bhatia, Bharathi, Jeyadeepa, Gaurav, Taneja, S, Balaji, Prashant, Shah, N, Saravanan, Vijay, Chauhan, Hemanth, Kumar, Chinnayin, Ponnuraja, Viktoriya, Livchits, Monica, Bahl, Umesh, Alavadi, K S, Sachdeva, Soumya, Swaminathan
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Treatment success rates for multidrug-resistant tuberculosis (MDR-TB) remain low globally. Availability of newer drugs has given scope to develop regimens that can be patient-friendly, less toxic, with improved outcomes. We proposed to determine the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::16590fda42f628d283cf574c3304a240
https://pubmed.ncbi.nlm.nih.gov/35767251
https://pubmed.ncbi.nlm.nih.gov/35767251
Autor:
Anna H. van’t Hoog, Puneet Dewan, Kuldeep Singh Sachdeva, Ranjani Ramachandran, Radhey Shyam Gupta, Susan van den Hof, Malik Parmar, Shubhangi Kulsange, Achuthan Sreenivas, Neeraj Raizada, Rahul Thakur, Umesh Alavadi, Nimalan Arinaminpathy, Bhavin Vadera, Ameet Babre, Mayank Ghedia, C. N. Paramasivan, Claudia M. Denkinger, Catharina Boehme, Christen Gray
Publikováno v:
PLoS ONE, 10(5). Public Library of Science
PLoS ONE, Vol 10, Iss 5, p e0126065 (2015)
PLoS ONE
PLoS ONE, Vol 10, Iss 5, p e0126065 (2015)
PLoS ONE
Background Xpert MTB/RIF, the first automated molecular test for tuberculosis, is transforming the diagnostic landscape in high-burden settings. This study assessed the impact of up-front Xpert MTB/RIF testing on detection of pulmonary tuberculosis (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6536ec92ae37b5a9149bc478d3f13f59
http://hdl.handle.net/10044/1/40182
http://hdl.handle.net/10044/1/40182
Autor:
Shikha Dhawan, Bhavin Vadera, Catharina Boehme, Kuldeep Singh Sachdeva, Shobha Ekka, Ashwini Khanna, Shubhangi Kulsange, Umesh Alavadi, Mayank Ghedia, Puneet Dewan, Malik Parmar, Radhey Shayam Gupta, Mini Khetrapal, Neeraj Raizada, Chinnambedu Nainarappan Paramsivan, Ameet Babre, Sreenivas Achuthan Nair, Christen Gray, Ranjani Ramachandran, Rahul Thakur
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 8, p e105346 (2014)
PLoS ONE, Vol 9, Iss 8, p e105346 (2014)
Background: Diagnosis of pulmonary tuberculosis (PTB) in children is challenging due to difficulties in obtaining good quality sputum specimens as well as the paucibacillary nature of disease. Globally a large proportion of pediatric tuberculosis (TB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::719ace169a3adb24ac7ce462d80c0e69
https://pubmed.ncbi.nlm.nih.gov/25140877
https://pubmed.ncbi.nlm.nih.gov/25140877
Autor:
Kuldeep Singh Sachdeva, Umesh Alavadi, Radhey Shyam Gupta, Achuthan Sreenivas, Rahul Thakur, Christen Gray, Shubhangi Kulsange, Ameet Babre, Malik Parmar, Catharina Boehme, Ranjani Ramachandran, Chinnambedu Nainarappan Paramsivan, Mayank Ghedia, Puneet Dewan, Neeraj Raizada, Bhavin Vadera, Balasangameshwara Hanumanthappa Vollepore
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 2, p e89301 (2014)
PLoS ONE, Vol 9, Iss 2, p e89301 (2014)
BackgroundXpert MTB/RIF is an automated cartridge-based nucleic acid amplification test that has demonstrated its potential to detect tuberculosis and rifampicin resistance with high accuracy. To assist scale-up decisions in India, a feasibility asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::509cb5d7159d33e04dcb8dcec9941baa
https://doi.org/10.1371/journal.pone.0089301
https://doi.org/10.1371/journal.pone.0089301